Company intelligence / Profile preview

Consultants in Medical Oncology and Hematology

Broomall, Pennsylvania, United Statescmoh.org ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

CMOH provides integrated cancer care including access to advanced treatments and clinical trials through its affiliation with US Oncology Research. The group delivers personalized oncology and hematology services across multiple locations in the Greater Philadelphia area, utilizing evidence-based protocols developed by Dr. John Sprandio. They participate actively in research studies to offer patients innovative therapies locally.

Therapeutic areas: OncologyHematology
Modalities: Small molecule (chemotherapy)Biologic (immunotherapy, monoclonal antibody)Cell therapy (CAR-T cell therapy)
Industry: Non-Academic Healthcare

Partnerships

US Oncology Network / US Oncology Research

Beyond the preview

Go deeper on Consultants in Medical Oncology and Hematology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Consultants in Medical Oncology and Hematology.

Explore the full profile